A study led by researchers at the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC) – a partnership between Leicester’s Hospitals, the University of Leicester and Loughborough University – has highlighted chronic levels of physical inactivity in people with kidney disease.
A clinical researcher at the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC) – a partnership between Leicester’s Hospitals, the University of Leicester and Loughborough University – has won the American Heart Association (AHA) Council on Lifestyle and Cardiometabolic Health Early Career Investigator Award, and first prize at the British Society of Heart Failure (BSH) Early Career Investigator Competition.
Over 35,000 adults undergo cardiac surgery in the UK every year with a further 1 million worldwide. While short-term results of surgery are excellent, many patients fail to obtain long-term benefits the reasons for which remain unclear. Academics from the University of Leicester are researching why this is and have defined the top priorities for UK cardiac surgery research.
More high-quality medical research is set to take place in the Midlands, following the launch of a new organisation. The Midlands Health Alliance (MHA) has been developed to showcase what the region has to offer with its cutting-edge health research – and is inviting industry partners to invest in the region.Read More
A vascular surgeon from Leicester’s Hospitals has been awarded a four-year grant worth over £1 million from the National Institute for Health Research (NIHR). Dr Athanasios Saratzis, who is also an Associate Professor at the University of Leicester, has been awarded the fellowship to develop and test a health intervention for men with aortic abdominal aneurysms (AAAs) to improve their health and reduce their chances of heart attacks and strokes.Read More
New research funded by the British Heart Foundation (BHF) at the University of Leicester could change the way people living with a debilitating heart condition are treated. The £2.7m clinical trial aims to identify the best time to operate on people living with severe aortic stenosis (AS).